PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride (original) (raw)
References
Adolfsson R, Gottfries CG, Roos E, Windblad B (1979) Postmortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J Neural Transm 45:81–105 Google Scholar
Andersen PH, Grönvald FC (1986) Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo. Life Sci 38:1507–1514 Google Scholar
Arnt J, Hyttel J (1985) Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, pergolide and LY171555 in 6-hydroxydopamine-lesioned rats. Psychopharmacology 85:346–352 Google Scholar
Bergström M, Boethius J, Eriksson L, Greitz T, Ribbe T, Widen L (1981) Head fixation device for reproducible positron alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 8:74–87 Google Scholar
Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A (1984) Characterization of the binding of 3H-SCH 23390, a selective D-1-receptor antagonist ligand, in rat striatum. Life Sci 35:1885–1893 Google Scholar
Creese I, Burt DR, Snyder SH (1976): Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481–483 Google Scholar
Creese I, Sibley DR, Hamblin MW, Leff SE (1983) The classification of dopamine receptors: relationship to radioligand binding. Annu Rev Neurosci 6:43–71 Google Scholar
Cross AJ, Crow TJ, Owen F (1981) 3H-Flupentixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors. Psychopharmacologia 74(2):122–124 Google Scholar
Dawson TM, Gehlert DR, Yamamura HI, Barnett A, Wamsley JK (1985) D-1 dopamine receptors in the rat brain: autoradiographic localization using 3H-SCH 23390. Eur J Pharmacol 108:323–325 Google Scholar
Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström C-G, Litton J-E, Sedvall G (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82:3863–3867 Google Scholar
Farde L, Hall H, Ehrin E, Sedvall G (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231:258–261 Google Scholar
Hall H, Wedel I (1986) Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. Acta Pharmacol Toxicol 58:368–373 Google Scholar
Hall H, Köhler C, Gawell L (1985) Some in vitro receptor binding properties of 3H-Eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain. Eur J Pharmacol 111:191–199 Google Scholar
Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth K-J, L»ngtröm B, Sedvall G (1986) Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D1 receptors using positron emission tomography. Int J Appl Radiat Isot 37:1039–1043 Google Scholar
Herrera-Marschitz M, Ungerstedt U (1985) Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats. Eur J Pharmacol 109:349–354 Google Scholar
Hyttel J (1983) SCH 23390 — the first selective dopamine D1 antagonist. Eur J Pharmacol 91:153–154 Google Scholar
Hyttel J, Christensen AV (1983) Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D1 and D2 receptors. J Neural Transm [Suppl] 18:157–164 Google Scholar
Iorio LC (1981) SCH 23390. A benzazepine with atypical effects on dopaminergic systems. The Parmacologist 23:136 Google Scholar
Jenner P, Testa B, van de Waterbeemd, Marsedn CD (1982) Interaction of substituted benzamide drugs with cerebral dopamine receptors. In: Ackenhei M, Matussek N (eds) Special aspects of psychopharmacology. Expansion Scientific Francaise, Paris, pp 153–170 Google Scholar
Jørgensen A (1978) A sensitive and specific radioimmunoassay for cis(Z)-flupentixol in human serum. Life Sci 23:1533–1542 Google Scholar
Jørgensen A, Andersen J, Bjorndal N, Dencker SJ, Lundin L, Malm U (1982) Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate. Psychopharmacology 77:58–65 Google Scholar
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–961 Google Scholar
Kebabian JW, Petzold GL, Greengard P (1972) Dopamine sensitive adenylate cyclase in the caudate nucleus of rat brain, and its similarity to the “dopamine receptor”. Proc Natl Acad Sci USA 69:2145–2149 Google Scholar
Köhler C, Radesäter A-C (1986) Autoradiographic visualization of dopamine D2 receptors in the monkey brain using the selective benzamide drug 3H-raclopride. Neurosci Lett 66:85–90 Google Scholar
Köhler C, Hall H, Ögren S-O, Gawell L (1985) Specific in vitro and in vivo binding of 3H-raclopride. Biochem Pharmacol 34:2251–2259 Google Scholar
de Paulis T, Kumar Y, Johansson L, Rämsby S, Hall H, Sällemark M, Ängeby-Möller K, Ögren SO (1986) Potential neuroleptic agents. 4. Chemistry, behavioural pharmacology and blocking of 3H-spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides. J Med Chem 29:61–69 Google Scholar
Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, adrenergic and histamine receptors to clinical potency. Am J Psychiatry 137:1518–1522 Google Scholar
Pimoule C, Schoemaker H, Reynolds GP, Langer SZ (1985) 3H-SCH 23390 labelled D1 dopamine receptors are unchanged in schizophrenia and parkinsons disease. Eur J Pharmacol 114:235–237 Google Scholar
Raisman R, Cash R, Ruberg M, Javoy-Agid F, Agid Y (1985) Binding of 3H-SCH 23390 to D1 receptors in the putamen of control and parkinsonian subjects. Eur J Pharmacol 113:467–468 Google Scholar
Schultz DW, Wyrick SD, Mailman RB (1985) 3H-SCH 23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system. Eur J Pharmacol 106:211–212 Google Scholar
Sedvall G, Farde L, Persson A, Wiesel F-A (1986a) Imaging of neurotransmitter receptors in the living human brain. Arch Gen Psychiatry 43:995–1005 Google Scholar
Sedvall G, Farde L, Stone-Elander S, Halldin C (1986b) Dopamine D1-receptor binding in the living human brain. In: Breese GR, Creese I (eds) Neurobiology of central D1-dopamine receptors. Plenum, New York, pp 119–124 Google Scholar
Sedvall G, Ehrin E, Farde L (1986c) Stereoselective binding of 11C-labelled piquindone (Ro 22-1319) to dopamine-D2 receptors in the living human brain. Human Psychopharmacol
Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717–719 Google Scholar
Seeman P, Ulpian C, Bergeron C, Riederer P, Jellinger K, Gabriel E, Peynolds GP, Tourtellotte WW (1984) Bimodal distribution of dopamine receptor densities in brain of schizophrenics. Science 225:728–731 Google Scholar
Tassin JP, Bockaert J, Blanc G, Stinus L, Thierry AM, Lavielle S, Premont J, Glowinski J (1978) Topographical distribution of dopaminergic innervation and dopaminergic receptors of the anterior cerebral cortex of the rat. Brain Res 106:241–251 Google Scholar
Titeler M (1984) Multiple dopamine receptors: In: Receptor binding studies in dopamine pharmacology. Dekker, New York Google Scholar
Wagner HN, Burns D, Dannals RF, Wong DF, L»ngström B, Duelfer T, Frost JJ, Ravert HT, Links JM, Rosenbloom SH, Lukas SE, Kramer AV, Kuhar MJ (1983) Imaging dopamine receptors in the human brain by positron emission tomography. Science 221:1264–1266 Google Scholar